We look forward to learning more about your needs:
Please contact  us or  visit our
  Learn What You Need to Know for Your Medicare Patients with Memory Complaints 
at a dinner and symposium.
 
SNMMI (Society of Nuclear Medicine and Molecular Imaging) Dinner Symposium with 2 CME credits 
Amyloid PET Imaging and Dementia: What You Need to Know for Your Medicare Patients with Memory Complaints
July 19, 2016 - San Francisco, CA
Mission Bay Conference Center
1675 Owens Street, San Francisco, CA 94143-3008 
6-8:30 p.m.
Parking onsite. Click  here for a map. 

Registration for this dinner symposium is complimentary with ample parking. 


This event provides 2 CME credits. Upon completion of this activity, the participant will be able to:
1. Explain the mechanism of how amyloid PET works.
2. Identify the appropriate indications and limitations of amyloid PET.
3. Understand how to provide Medicare patients access to amyloid PET.
 
When Your Patients Have Memory Loss
 
 
Lapses in memory and confused thinking could be normal signs of getting older, or they could suggest something more serious, such as Alzheimer's disease. 
 
We are proud to be a site for the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study. This $100 million study will be the largest of its kind, eventually enrolling over 18,000 patients. The study was developed by the IDEAS study group, which included Gil Rabinovici, MD, of the UCSF Department of Neurology; Maria Carrillo, PhD, chief science officer of the Alzheimer's Association, and other partners. The IDEAS Study is led by the Alzheimer's Association and the American College of Radiology Imaging Network (ACRIN) and managed by the American College of Radiology (ACR). 

Meet the multi-disciplinary team presenting at the symposium.
Miguel Hernandez Pampaloni, MD, PhD


Miguel Hernandez Pampaloni, MD, PhD, is a globally recognized expert in the field of positron emission tomography (PET). He is chief of the Department of Nuclear Medicine at UCSF.



Gil Rabinovici, MD



Gil Rabinovici, MD, is a neurologist who leads the nationwide Imaging Dementia--Evidence for Amyloid Scanning (IDEAS) Study, a collaborative study he developed with the Alzheimer's Association to determine the usefulness of PET scans in detecting amyloid plaques, a key feature of Alzheimer's disease, in the brain.



Michael Weiner, MD


To meet the goal of defeating Alzheimer's disease, Michael Weiner, MD, encourages patients to sign up for the  Brain Health Registry, a global unified effort to accelerate cures for many brain disorders including Alzheimer's. Dr. Weiner is professor in residence in the departments of Radiology, Medicine, Neurology, and Psychiatry. 

Amyloid PET Imaging and Dementia: What You Need to Know for Your Medicare Patients with Memory Complaints
 Tuesday, July 19, 2016 - San Francisco, CA
Mission Bay Conference Center


6:00-6:20   Reception and buffet
6:20-6:30   Welcome and opening remarks, Miguel Pampaloni, MD; Elizabeth Edgerly, PhD, Chief Program Officer, Alzheimer's Association, Northern CA and Northern NV
6:30-7:00   Advances in Diagnosis and Treatment, Michael Weiner, MD
7:00-7:30   Imaging for Dementia Care, Miguel Pampaloni, MD
7:30-8:00   Helping Dementia Patients Through Clinical Trials: National IDEAS Trial, Gil Rabinovici, MD
8:00-8:30   Panel discussion
 
What You Said
 
Thanks to all of you who responded to our communications survey. We learned that  LinkedIn is the social site you use most for professional purposes, while Facebook prevails for communication with family and friends. 
 
This month we'd like to learn  which medical journals you refer to most often. Click  here for a one-question survey. We'll let you know our results next month, and you can join the conversation on our LinkedIn group  here

The Department of Radiology and Biomedical Imaging at the University of California, San Francisco is a leading health sciences center focused on serving patients, conducting research, and training the next generation of radiologists. We are proud to have some of the foremost names in diagnost ic, therapeutic, and interventional radiology developing promising new approaches to identify and treat disease. We are a patient-centered team, and are proud that the community recognizes us for our compassion and care.
It is our privilege and pleasure to work with you by providing world-class imaging services to your patients. We look forward to partnering with you to deliver the best possible patient outcomes. Please call our scheduling department at (415) 353-2573 or contact us anytime.
We look forward to learning more about your needs:

To refer a patient, please call (415) 353-2573.
Contact our administration.
Visit our San Francisco locations.

See what's happening on our social sites: